Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
27-May-2026 | 543.6 | 549.1 | 534 | 536.15 | 7,988 | 7,57,54,444.3 | 78,460 |
29-May-2026 | 531 | 565 | 531 | 555.35 | 18,416 | 25,39,68,881.15 | 3,06,674 |
01-Jun-2026 | 560 | 560 | 535.05 | 540.85 | 9,205 | 8,14,04,693.4 | 70,522 |
02-Jun-2026 | 540.85 | 549.95 | 528.9 | 541.5 | 14,736 | 10,31,05,081.8 | 1,02,753 |
03-Jun-2026 | 538 | 541.7 | 527.05 | 536.15 | 4,821 | 3,85,18,893.05 | 38,062 |
04-Jun-2026 | 530.1 | 551 | 530.1 | 544.15 | 18,676 | 11,61,41,425.1 | 99,018 |
05-Jun-2026 | 544.15 | 554.2 | 530.4 | 533.2 | 9,745 | 8,88,27,619.4 | 84,904 |
08-Jun-2026 | 520 | 538.8 | 520 | 529.65 | 8,417 | 4,32,26,897.6 | 38,047 |
09-Jun-2026 | 537.05 | 539 | 529.4 | 535.55 | 4,394 | 2,89,91,843.2 | 29,528 |
10-Jun-2026 | 538.7 | 539.65 | 522.05 | 524.45 | 6,846 | 3,35,55,980.8 | 37,533 |
11-Jun-2026 | 522.1 | 537.3 | 515 | 520.15 | 10,909 | 6,44,39,926.9 | 57,077 |
12-Jun-2026 | 524.95 | 533.3 | 520.1 | 530.7 | 8,580 | 3,48,35,491.6 | 33,514 |
15-Jun-2026 | 539.85 | 539.9 | 523.25 | 525.9 | 11,293 | 6,13,00,100 | 69,570 |
16-Jun-2026 | 529 | 556.6 | 524.9 | 534.15 | 32,492 | 34,57,64,667.55 | 2,51,429 |
17-Jun-2026 | 538.4 | 559.85 | 538 | 545.6 | 21,489 | 21,04,81,214.4 | 1,76,148 |
18-Jun-2026 | 546.4 | 559.2 | 536 | 542.5 | 12,889 | 13,21,18,967.85 | 1,12,967 |
19-Jun-2026 | 540 | 556.55 | 540 | 552.75 | 10,095 | 12,50,75,262.05 | 1,09,174 |
22-Jun-2026 | 555.9 | 558.8 | 526 | 540.5 | 25,462 | 25,29,78,492.45 | 2,36,342 |
23-Jun-2026 | 537.6 | 551.35 | 537.6 | 543.25 | 12,491 | 7,66,18,078.25 | 67,018 |
24-Jun-2026 | 543.25 | 558.8 | 538.6 | 553.2 | 11,022 | 10,42,99,630.2 | 1,21,715 |
25-Jun-2026 | 557.9 | 563.5 | 540.65 | 543.35 | 10,143 | 10,98,45,428.35 | 84,436 |
Metropolis Healthcare said it plans to expand its genomic test portfolio to more than 500 advanced tests over the next two to three years
The deal includes a deferred payment of ₹1.7 crore, which will be disbursed as per the terms of the business transfer agreement, the company said in a regulatory filing.
The EBITDA margin fell to 18% in Q4 FY25 from 24.2% in Q4 FY24, reflecting a fall in operational efficiency or profitability.
The EBITDA margin was stable at 22.3% and did not change much from the year-ago period.
This is a 100% stake purchase that will be funded through 55% cash and 45% equity swap. It expects completion in 60 days, after shareholders give their nod.
Here are some of the stocks that may see significant price movement today: Tata Motors, Asian Paints, Divi’s Laboratories, etc.
Here are some of the stocks that may see significant price movement today: Titan Company, HDFC Bank, IndusInd Bank, etc.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
